Company: AILIM
Filing Date: 2025-05-05
Form Type: 10-Q
Source: 0001002910-25-000098
Chunk: 61

Company: Ameren Illinois Co
Filing Date: 2025-05-05
Form: 10-Q
Item: Part I, Item 1
Chunk 61
---
 in various equity method investments, primarily to advance clean and resilient energy technologies, totaling $71 million and $74 million, respectively, included in “Other assets” on Ameren’s consolidated balance sheet. Any earnings or losses related to these investments are included in “Other Income, Net” on Ameren’s consolidated statement of income and comprehensive income. Ameren is not the primary beneficiary of these investments because it does not have the power to direct matters that most significantly affect the activities of these variable interest entities. As of March 31, 2025, Ameren’s maximum exposure to loss related to these variable interest entities is limited to the investment in these partnerships of $71 million plus associated outstanding funding commitments of $34 million.COLIAmeren (parent) and Ameren Illinois have COLI, which is recorded at the net cash surrender value. The net cash surrender value is the amount that can be realized under the insurance policies at the balance sheet date. As of March 31, 2025, the cash surrender value of COLI at Ameren and Ameren Illinois was $259 million (December 31, 2024 – $260 million) and $120 million (December 31, 2024 – $118 million), respectively, while total borrowings against the policies were $110 million (December 31, 2024 – $110 million) at both Ameren and Ameren Illinois. Ameren and Ameren Illinois have the right to offset the borrowings against the cash surrender value of the policies and, consequently, present the net asset in “Other assets” on their respective balance sheets. The net cash surrender value of Ameren’s COLI is affected by the investment performance of a separate account in which Ameren holds a beneficial interest.

NOTE 2 – RATE AND REGULATORY MATTERS

Below is a summary of updates to significant regulatory proceedings and related legal proceedings. See Note 2 – Rate and Regulatory Matters under Part II, Item 8, of the Form 10-K for additional information and a summary of our regulatory frameworks. We are unable to predict the ultimate outcome of these matters, the timing of final decisions of the various agencies and courts, or the impact on our results of operations, financial position, or liquidity.MissouriMissouri Senate Bill 4In April 2025, Missouri Senate Bill 4 was enacted and will become effective in August 2025. The law includes certain provisions that affect the regulation of Amer